• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?

作者信息

Hien Doan Luong, Pham Brandon Huy, Nguyen Quan Dong

机构信息

Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California, USA.

Pham Ngoc Thach University of Medicine, Saigon, Vietnam.

出版信息

J Ophthalmic Vis Res. 2020 Oct 25;15(4):442-445. doi: 10.18502/jovr.v15i4.7777. eCollection 2020 Oct-Dec.

DOI:10.18502/jovr.v15i4.7777
PMID:33133433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7591831/
Abstract
摘要

相似文献

1
How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?对于常规免疫调节治疗难治或不耐受的HLA - B27相关眼部炎症，我们该如何处理？
J Ophthalmic Vis Res. 2020 Oct 25;15(4):442-445. doi: 10.18502/jovr.v15i4.7777. eCollection 2020 Oct-Dec.
2
Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy.英夫利昔单抗治疗对传统免疫调节疗法难治或不耐受的 HLA - B27 相关眼部炎症的疗效与安全性
J Ophthalmic Vis Res. 2020 Oct 25;15(4):459-469. doi: 10.18502/jovr.v15i4.7786. eCollection 2020 Oct-Dec.
3
Clinical spectrum of HLA-B27-associated ocular inflammation.HLA-B27 相关性眼内炎症的临床谱。
Nepal J Ophthalmol. 2022 Jul;14(28):116-134. doi: 10.3126/nepjoph.v14i2.50679.
4
Double trouble: a patient with both HLA-B27 anterior uveitis and HLA-A29 birdshot chorioretinitis.双重麻烦：一位同时患有HLA - B27前葡萄膜炎和HLA - A29鸟枪弹样脉络膜视网膜病变的患者。
J Ophthalmic Inflamm Infect. 2014 Dec;4(1):28. doi: 10.1186/s12348-014-0028-6. Epub 2014 Nov 26.
5
Clinical Spectrum of HLA-B27-associated Ocular Inflammation.HLA - B27相关性眼部炎症的临床谱
Ocul Immunol Inflamm. 2017 Aug;25(4):569-576. doi: 10.1080/09273948.2016.1185527. Epub 2016 Jul 18.
6
Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?脊柱关节炎患者葡萄膜炎治疗的进展——是时候采用生物疗法了吗？
Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122.
7
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.HLA - B27相关性慢性葡萄膜炎患者早期和晚期免疫调节治疗的结果
Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1000-5. doi: 10.1007/s00417-003-0789-3. Epub 2003 Nov 7.
8
Biologic Therapy for HLA-B27-associated Ocular Disorders.HLA - B27相关眼部疾病的生物治疗
Ocul Immunol Inflamm. 2017 Apr;25(2):169-178. doi: 10.1080/09273948.2016.1234625. Epub 2016 Oct 17.
9
Acute anterior uveitis and HLA-B27.急性前葡萄膜炎与HLA - B27
Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88. doi: 10.1016/j.survophthal.2005.04.003.
10
Ocular Decompression Retinopathy after Cataract Surgery in HLA-B27 Associated Anterior Uveitis.HLA - B27相关性前葡萄膜炎患者白内障手术后的眼部减压性视网膜病变
Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1977-1979. doi: 10.1080/09273948.2021.1912361. Epub 2021 Jul 9.

本文引用的文献

1
Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy.英夫利昔单抗治疗对传统免疫调节疗法难治或不耐受的 HLA - B27 相关眼部炎症的疗效与安全性
J Ophthalmic Vis Res. 2020 Oct 25;15(4):459-469. doi: 10.18502/jovr.v15i4.7786. eCollection 2020 Oct-Dec.
2
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.托珠单抗在 COVID-19 中的应用的原理和证据：系统评价。
Pulmonology. 2021 Jan-Feb;27(1):52-66. doi: 10.1016/j.pulmoe.2020.07.003. Epub 2020 Jul 20.
3
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.玻璃体内注射西罗莫司治疗后部非感染性葡萄膜炎的疗效和安全性：西罗莫司评估双盲葡萄膜炎治疗（SAKURA）计划的研究结果。
Ophthalmology. 2020 Oct;127(10):1405-1415. doi: 10.1016/j.ophtha.2020.03.033. Epub 2020 Apr 3.
4
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.托珠单抗治疗伴有炎症过度反应和急性呼吸衰竭的重症 COVID-19 肺炎：意大利布雷西亚单中心 100 例患者研究。
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
5
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.长期使用英夫利昔单抗治疗难治性非感染性小儿葡萄膜炎的疗效及治疗依从性对疾病控制的影响。
Pediatr Rheumatol Online J. 2019 Nov 29;17(1):79. doi: 10.1186/s12969-019-0383-9.
6
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.吗替麦考酚酯与甲氨蝶呤治疗葡萄膜炎患者的激素撤药作用：一项随机临床试验。
JAMA. 2019 Sep 10;322(10):936-945. doi: 10.1001/jama.2019.12618.
7
Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.沙利鲁单抗治疗后段非感染性葡萄膜炎（SARIL-NIU）的疗效和安全性： 2 期 SATURN 研究。
Ophthalmology. 2019 Mar;126(3):428-437. doi: 10.1016/j.ophtha.2018.09.044. Epub 2018 Oct 11.
8
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.玻璃体内注射西罗莫司治疗非感染性葡萄膜炎：临床前和临床研究的进展。
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
9
2018 update of the EULAR recommendations for the management of Behçet's syndrome.2018 年更新的欧洲抗风湿病联盟白塞病治疗推荐。
Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.
10
Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent.用于非感染性全葡萄膜炎的皮下缓释促肾上腺皮质激素凝胶：对一种古老药物的重新评估
Am J Ophthalmol Case Rep. 2016 Sep 28;4:78-82. doi: 10.1016/j.ajoc.2016.09.004. eCollection 2016 Dec.